Literature DB >> 28060378

CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages.

Patrick S Murphy1,2, Jing Wang3, Samir P Bhagwat3, Joshua C Munger1,4, William J Janssen5, Terry W Wright1,3, Michael R Elliott1,2.   

Abstract

The phagocytosis of apoptotic cells (efferocytosis) shifts macrophages to an anti-inflammatory state through a set of still poorly understood soluble and cell-bound signals. Apoptosis is a common feature of inflamed tissues, and efferocytosis by tissue macrophages is thought to promote the resolution of inflammation. However, it is not clear how the exposure of tissue macrophages to inflammatory cues (e.g., PAMPs, DAMPs) in the early stages of inflammation affects immune outcomes of macrophage-apoptotic cell interactions occurring at later stages of inflammation. To address this, we used low-dose endotoxin conditioning (LEC, 1 ng/ml LPS 18 h) of mouse resident peritoneal macrophages (RPMФ) to model the effects of suboptimal (i.e., non-tolerizing), antecedent TLR activation on macrophage inflammatory responses to apoptotic cells. Compared with unconditioned macrophages (MФ), LEC-MФ showed a significant enhancement of apoptotic cell-driven suppression of many inflammatory cytokines (e.g., TNF, MIP-1β, MCP-1). We then found that enzymatic depletion of adenosine or inhibition of the adenosine receptor A2a on LEC-MФ abrogated apoptotic cell suppression of TNF, and this suppression was entirely dependent on the ecto-enzyme CD73 (AMPadenosine) but not CD39 (ATPAMP), both of which are highly expressed on RPMФ. In addition to a requirement for CD73, we also show that Adora2a levels in macrophages are a critical determinant of TNF suppression by apoptotic cells. LEC treatment of RPMФ led to a ~3-fold increase in Adora2a and a ~28-fold increase in adenosine sensitivity. Moreover, in RAW264.7 cells, ectopic expression of both A2a and CD73 was required for TNF suppression by apoptotic cells. In mice, mild, TLR4-dependent inflammation in the lungs and peritoneum caused a rapid increase in macrophage Adora2a and Adora2b levels, and CD73 was required to limit neutrophil influx in this peritonitis model. Thus immune signaling via the CD73-A2a axis in macrophages links early inflammatory events to subsequent immune responses to apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060378      PMCID: PMC5344214          DOI: 10.1038/cdd.2016.159

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  44 in total

Review 1.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

2.  Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.

Authors:  György Haskó; Balázs Csóka; Balázs Koscsó; Rachna Chandra; Pál Pacher; Linda F Thompson; Edwin A Deitch; Zoltán Spolarics; László Virág; Pál Gergely; Rolando H Rolandelli; Zoltán H Németh
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

3.  The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells.

Authors:  Natacha Ipseiz; Stefan Uderhardt; Carina Scholtysek; Martin Steffen; Gernot Schabbauer; Aline Bozec; Georg Schett; Gerhard Krönke
Journal:  J Immunol       Date:  2014-04-16       Impact factor: 5.422

4.  Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation.

Authors:  Yan Qu; Shahram Misaghi; Kim Newton; Laurie L Gilmour; Salina Louie; James E Cupp; George R Dubyak; David Hackos; Vishva M Dixit
Journal:  J Immunol       Date:  2011-04-20       Impact factor: 5.422

Review 5.  Immune cell regulation by autocrine purinergic signalling.

Authors:  Wolfgang G Junger
Journal:  Nat Rev Immunol       Date:  2011-02-18       Impact factor: 53.106

6.  Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.

Authors:  Lauren J Murphree; Gail W Sullivan; Melissa A Marshall; Joel Linden
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 7.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

8.  Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion.

Authors:  Mark Lucas; Lynda M Stuart; John Savill; Adam Lacy-Hulbert
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

Review 9.  Nucleotide signalling during inflammation.

Authors:  Marco Idzko; Davide Ferrari; Holger K Eltzschig
Journal:  Nature       Date:  2014-05-15       Impact factor: 49.962

10.  Apoptotic cell clearance and its role in the origin and resolution of chronic inflammation.

Authors:  Luis Enrique Muñoz; Christian Berens; Kirsten Lauber; Udo S Gaipl; Martin Herrmann
Journal:  Front Immunol       Date:  2015-03-25       Impact factor: 7.561

View more
  25 in total

1.  Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.

Authors:  Jonathan J Pinney; Fátima Rivera-Escalera; Charles C Chu; Hannah E Whitehead; Karl R VanDerMeid; Ashley M Nelson; Michelle C Barbeau; Clive S Zent; Michael R Elliott
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

2.  STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice.

Authors:  Wei Cai; Xuejiao Dai; Jie Chen; Jingyan Zhao; Mingyue Xu; Lili Zhang; Boyu Yang; Wenting Zhang; Marcelo Rocha; Toshimasa Nakao; Julia Kofler; Yejie Shi; R Anne Stetler; Xiaoming Hu; Jun Chen
Journal:  JCI Insight       Date:  2019-10-17

Review 3.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

4.  High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging.

Authors:  Charles C Chu; Jonathan J Pinney; Hannah E Whitehead; Fatima Rivera-Escalera; Karl R VanDerMeid; Clive S Zent; Michael R Elliott
Journal:  J Cell Sci       Date:  2020-03-05       Impact factor: 5.285

5.  Sirt3 inhibits cerebral ischemia-reperfusion injury through normalizing Wnt/β-catenin pathway and blocking mitochondrial fission.

Authors:  Hao Zhao; Yongchun Luo; Lihua Chen; Zhenhai Zhang; Chunsen Shen; Yunjun Li; Ruxiang Xu
Journal:  Cell Stress Chaperones       Date:  2018-06-03       Impact factor: 3.667

6.  Mst1 promotes cardiac ischemia-reperfusion injury by inhibiting the ERK-CREB pathway and repressing FUNDC1-mediated mitophagy.

Authors:  Wancheng Yu; Mei Xu; Tao Zhang; Qian Zhang; Chengwei Zou
Journal:  J Physiol Sci       Date:  2018-06-30       Impact factor: 2.781

Review 7.  Targeting CD73 to augment cancer immunotherapy.

Authors:  Meejeon Roh; Derek A Wainwright; Jennifer D Wu; Yong Wan; Bin Zhang
Journal:  Curr Opin Pharmacol       Date:  2020-08-07       Impact factor: 5.547

8.  Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity.

Authors:  Lynn Pezzanite; Lyndah Chow; Dean Hendrickson; Daniel L Gustafson; A Russell Moore; Jason Stoneback; Gregg M Griffenhagen; Gabriella Piquini; Jennifer Phillips; Paul Lunghofer; Steven Dow; Laurie R Goodrich
Journal:  Front Vet Sci       Date:  2021-05-21

Review 9.  Glucose Metabolism: The Metabolic Signature of Tumor Associated Macrophage.

Authors:  Qi Zhang; Junli Wang; Dipesh Kumar Yadav; Xueli Bai; Tingbo Liang
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

10.  Elevated Pressure Changes the Purinergic System of Microglial Cells.

Authors:  Ana C Rodrigues-Neves; Inês D Aires; Joana Vindeirinho; Raquel Boia; Maria H Madeira; Francisco Q Gonçalves; Rodrigo A Cunha; Paulo F Santos; António F Ambrósio; Ana R Santiago
Journal:  Front Pharmacol       Date:  2018-01-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.